Suppr超能文献

宫颈人乳头瘤病毒(HPV)筛查试验的假阳性结果

False positive cervical HPV screening test results.

作者信息

Schiffman Mark, de Sanjose Silvia

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, MD, 20892, USA.

Sexual and Reproductive Health Program, PATH, Seattle, 98121, USA; Ciber Epidemiologia y Salud Publica, Barcelona, Spain.

出版信息

Papillomavirus Res. 2019 Jun;7:184-187. doi: 10.1016/j.pvr.2019.04.012. Epub 2019 Apr 25.

Abstract

In cervical cancer screening, HPV testing is best at reassuring women when they are negative, but proper management of HPV positives is still evolving. Most HPV infections are benign, and over-reacting clinically to HPV positivity can cause psychological and possible iatrogenic physical (e.g., obstetrical) harm. We describe the built-in false positives in current tests, and the real harm that can result when the meaning of such false positive HPV tests is misunderstood. We suggest steps that could reduce harm being done by flawed tests and excessive clinical responses to positive HPV testing. We focus the discussion by presenting an illustrative case.

摘要

在宫颈癌筛查中,HPV检测在结果为阴性时最能让女性安心,但对HPV阳性结果的妥善管理仍在不断发展。大多数HPV感染是良性的,临床上对HPV阳性反应过度会造成心理伤害,还可能造成医源性身体伤害(如产科方面的)。我们描述了当前检测中固有的假阳性情况,以及当这种HPV检测假阳性的意义被误解时可能导致的实际危害。我们提出了一些措施,以减少有缺陷的检测以及对HPV检测阳性的过度临床反应所造成的危害。我们通过展示一个示例病例来集中讨论。

相似文献

1
False positive cervical HPV screening test results.
Papillomavirus Res. 2019 Jun;7:184-187. doi: 10.1016/j.pvr.2019.04.012. Epub 2019 Apr 25.
2
Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening.
J Clin Microbiol. 2019 Jan 30;57(2). doi: 10.1128/JCM.01239-18. Print 2019 Feb.
5
Aptima HPV Assay versus Hybrid Capture 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial.
J Clin Virol. 2017 Feb;87:23-29. doi: 10.1016/j.jcv.2016.12.004. Epub 2016 Dec 11.
9
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Clin Microbiol Infect. 2015 Sep;21(9):817-26. doi: 10.1016/j.cmi.2015.04.015. Epub 2015 May 1.

引用本文的文献

1
2
A Deep Learning Model for Cervical Optical Coherence Tomography Image Classification.
Diagnostics (Basel). 2024 Sep 11;14(18):2009. doi: 10.3390/diagnostics14182009.
4
FAM19A4 and hsa-miR124-2 Double Methylation as Screening for ASC-H- and CIN1 HPV-Positive Women.
Pathogens. 2024 Apr 11;13(4):312. doi: 10.3390/pathogens13040312.
5
Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening.
Cancers (Basel). 2024 Mar 28;16(7):1322. doi: 10.3390/cancers16071322.
7
Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing.
PLOS Glob Public Health. 2023 Aug 16;3(8):e0001982. doi: 10.1371/journal.pgph.0001982. eCollection 2023.
8
Performance of screening tools for cervical neoplasia among women in low- and middle-income countries: A systematic review and meta-analysis.
PLOS Glob Public Health. 2023 Feb 23;3(2):e0001598. doi: 10.1371/journal.pgph.0001598. eCollection 2023.
9
The clinical relevance of human papillomavirus negative status in unsatisfactory cervical cytology.
Arch Gynecol Obstet. 2023 Apr;307(4):1021-1025. doi: 10.1007/s00404-022-06870-0. Epub 2022 Dec 9.

本文引用的文献

1
Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58.
JNCI Cancer Spectr. 2019 Jan 7;2(4):pky045. doi: 10.1093/jncics/pky045. eCollection 2018 Oct.
2
Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing.
J Clin Microbiol. 2019 Apr 26;57(5). doi: 10.1128/JCM.01794-18. Print 2019 May.
3
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2018 Aug 21;320(7):674-686. doi: 10.1001/jama.2018.10897.
7
Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease.
Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD012847. doi: 10.1002/14651858.CD012847.
8
Worldwide burden of cancer attributable to HPV by site, country and HPV type.
Int J Cancer. 2017 Aug 15;141(4):664-670. doi: 10.1002/ijc.30716. Epub 2017 Jun 8.
10
A cohort study of cervical screening using partial HPV typing and cytology triage.
Int J Cancer. 2016 Dec 1;139(11):2606-15. doi: 10.1002/ijc.30375. Epub 2016 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验